|
HY-P74743-10ug
|
MedChemexpress LLC
|
MRAP, Human (HEK293, hFc)
|
|
|
|
|
HY-P74743-5ug
|
MedChemexpress LLC
|
MRAP, Human (HEK293, hFc)
|
|
|
|
|
HY-P74743-50ug
|
MedChemexpress LLC
|
MRAP, Human (HEK293, hFc)
|
|
|
|
|
HY-79593S2-1mg
|
MedChemexpress LLC
|
MRE-269-d7 [CAS 1265295-20-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-79593S2-5mg
|
MedChemexpress LLC
|
MRE-269-d7 [CAS 1265295-20-2]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-130118-10mg
|
MedChemexpress LLC
|
MRGPRX1 agonist 1 [CAS 2377379-39-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-130118-100mg
|
MedChemexpress LLC
|
MRGPRX1 agonist 1 [CAS 2377379-39-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-130118-25mg
|
MedChemexpress LLC
|
MRGPRX1 agonist 1 [CAS 2377379-39-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-130118-5mg
|
MedChemexpress LLC
|
MRGPRX1 agonist 1 [CAS 2377379-39-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-130118-50mg
|
MedChemexpress LLC
|
MRGPRX1 agonist 1 [CAS 2377379-39-8]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-130118-1mL
|
MedChemexpress LLC
|
MRGPRX1 agonist 1 [CAS 2377379-39-8] (10mM in DMSO)
|
|
Neuroscience-Neuromodulation
|
|
|
HY-145997-1mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-1 [CAS 2492596-61-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-145997-10mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-1 [CAS 2492596-61-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-145997-5mg
|
MedChemexpress LLC
|
MRGPRX4 modulator-1 [CAS 2492596-61-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-135280-1mg
|
MedChemexpress LLC
|
MRL-650 [CAS 852315-00-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-149167-1mg
|
MedChemexpress LLC
|
mRNA-Encapsulating Lipid Excipient 1 [CAS 2230647-37-5]
|
|
Metabolism-protein/nucleotide metabolism
|
|
|
HY-108658-10mg
|
MedChemexpress LLC
|
MRS2500 (tetraammonium) [CAS 630103-23-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-108658-2mg
|
MedChemexpress LLC
|
MRS2500 (tetraammonium) [CAS 630103-23-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-108658-5mg
|
MedChemexpress LLC
|
MRS2500 (tetraammonium) [CAS 630103-23-0]
|
|
Neuroscience-Neuromodulation
|
|
|
HY-110202-1mg
|
MedChemexpress LLC
|
MRS5698 [CAS 1377273-00-1]
|
|
COVID-19-immunoregulation
|
|
|
HY-134813-1mg
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8]
|
|
|
|
|
HY-134813-10mg
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8]
|
|
|
|
|
HY-134813-5mg
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8]
|
|
|
|
|
HY-134813-1mL
|
MedChemexpress LLC
|
MRTX1133 [CAS 2621928-55-8] (10mM in DMSO)
|
|
|
|
|
HY-120444-1mg
|
MedChemexpress LLC
|
MS0124 [CAS 1197196-63-6]
|
|
Cancer-programmed cell death
|
|
